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Introduction
Apixaban is a direct oral anticoagulant (DOAC) approved by 
the US Food and Drug Administration (FDA) for use in non-
valvular atrial fibrillation for stroke prevention.1 DOACs are 
associated with an increased risk of bleeding. Recently, 
atraumatic splenic rupture has been reported with their 
increasing use.2–8 We present a case of a spontaneous splenic 
rupture with hemorrhagic shock requiring emergent splenic 
artery embolization and splenectomy in the setting of apixa-
ban use.
Case description
An 86-year-old gentleman presented to the emergency 
department (ED) after a fall due to orthostatic syncope. He 
had complained of left upper quadrant abdominal pain the 
night prior. According to his wife, he was restless overnight 
and had gone to the bathroom that morning when she heard 
him fall. The patient denied trauma prior to the onset of 
abdominal pain, recent sore throat, fever, chills, night sweats, 
weight loss, fatigue, reflux, or recent travel. His history was 
significant for atrial fibrillation, coronary artery disease, 
hypertension, hyperlipidemia, and type II diabetes mellitus. 
He did not have a history of bleeding or clotting disorders. 
His home medications included apixaban 5 mg two times 
daily, aspirin 81 mg daily, atorvastatin 40 mg daily, carve-
dilol 12.5 mg two times daily, hydrochlorothiazide 25 mg 
daily, lisinopril 10 mg daily, and metformin 500 mg two 
times daily. He was not on any medications with CYP3A4 or 
P-gp-inhibiting activity. On presentation, his temperature 
was 36.7°C (98.1°F), blood pressure was 107/67 mm Hg 
with nadir of 74/46 mm Hg, heart rate was 65/min, and res-
piratory rate was 16 breaths per minute. Physical examina-
tion was significant for diffuse bilateral abdominal tenderness 
without any guarding or rebound tenderness. He was lethar-
gic and slow to follow commands. The remainder of the 
physical examination was normal.
Serologic testing revealed his hemoglobin was 11.8 g/dL 
(reference range: 14.0–17.5 g/dL), down from a baseline of 
14 g/dL. Coagulation panel revealed international normalized 
ratio (INR) of 1.2 (reference range: 0.9–1.1), prothrombin time 
(PT) of 14.9 s (reference range: 11.7–14.1 s), activated partial 
thromboplastin time (aPTT) of 28 s (reference range: 23–34 s), 
and platelets 146,000/µL (reference range: 130,000–400,000/µL). 
His random blood sugar was 268 mg/dL (reference range: 70–
99 mg/dL). Computed tomography (CT) of the abdomen/pelvis 
with contrast showed active extravasation from the spleen with 
a large subcapsular hematoma and hemoperitoneum (Figure 
1). CT head with cervical spine was negative for acute intracra-
nial mass or hemorrhage, fracture, or focal bony lesions. He 
was given 2.5 L of normal saline to maintain his systolic blood 
pressure over 100 mg Hg. He received a unit of prothrombin 
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complex concentrate (PCC), 2 units of packed red blood cells 
(PRBCs), and 2 units of fresh frozen plasma (FFP) in the ED to 
reverse his coagulopathy. The patient was taken for emergent 
splenic arteriography and embolization. Embolization was ini-
tially pursued to avoid the need for an exploratory laparotomy 
as his blood pressures stabilized with initial volume resuscita-
tion. Images after contrast injection demonstrated a small area 
of extravasation from the inferior tip of the spleen in the area of 
the abnormality seen on CT scan. The proximal third of the 
splenic artery was successfully embolized with a 10-mm 
Amplatzer 2 plug device. Post procedure, the patient’s blood 
pressure improved to 154/47 mm Hg. He was then admitted to 
the surgical intensive care unit for close monitoring. Over the 
course of hours, the patient again deteriorated and was hypo-
tensive with systolic blood pressure in the 80s. He was short of 
breath. Bedside focused assessment with sonography for 
trauma (FAST) scan showed a flat inferior vena cava and a 
large hemoperitoneum. With concern for ongoing bleed, the 
patient was transfused 2 units of PRBCs and was taken to the 
operating room for exploratory laparotomy and splenectomy 
for a ruptured subcapsular splenic hematoma. Around 1500 mL 
of bloody fluid was removed from the peritoneum. No retrop-
eritoneal hematoma was noted. Splenic pathology revealed 
capsular disruption with associated subcapsular and intra-
parenchymal hemorrhage, and numerous macrophages within 
the splenic parenchyma likely secondary to a reactive phenom-
enon. His hematoma was thought to be related to apixaban use 
in the absence of trauma or splenic pathology. Patient’s postop-
erative hospital stay was unremarkable. His hemoglobin was 
stable at 11.7 g/dL. He was discharged on day 5 with recom-
mendations to resume apixaban and aspirin.
Discussion
Spontaneous splenic rupture is a rare entity but has been 
noted to occur with infections such as infectious mononu-
cleosis; hematologic neoplasms such as leukemia and 
lymphoma; non-infectious, inflammatory disorders such as 
amyloidosis and polyarteritis nodosa; medications; dialysis; 
and pregnancy.9,10 Orloff and Peskin11 established four crite-
ria for spontaneous rupture of the normal spleen to which a 
fifth criterion was later added by Crate and Payne.12 In our 
case, the biopsy was negative for infiltrating atypical lym-
phocytes or monocytes that would be suggestive of infec-
tion, neoplasm, or inflammatory disorders. His renal function 
was unremarkable. Although he had a fall, this was preceded 
by left upper quadrant pain. Thus, we believe that his ortho-
static syncope was a manifestation of low intravascular vol-
ume status from preceding splenic hemorrhage. We were not 
able to find an etiology for splenic rupture other than apixa-
ban use.
DOACs, apixaban, rivaroxaban, and dabigatran have all 
been associated with atraumatic splenic rupture in previous 
literature.2–8 This is the third case related to apixaban.7,8 
Apixaban has anticoagulant properties by inhibiting free and 
bound form of factor Xa.1 Lowry and Goldner7 suggest that 
apixaban may worsen previously undetected microtrauma 
that may lead to splenic hemorrhage. Concomitant use of 
antiplatelets, p-glycoprotein, and CYP3A4-inhibiting medi-
cations and poor renal function all increase the risk of bleed-
ing with DOACs.2 Our patient was not on any medications 
that were associated with p-glycoprotein and CYP3A4-
inhibiting activity. Atraumatic splenic rupture was noted 
early after initiation of a DOAC. Splenic rupture was 
reported 1 day, 2 days, and 2 months after initiation of dabi-
gatran,6 apixaban,8 and rivaroxaban,4 respectively. Left-
sided abdominal pain that may radiate to the shoulder, 
declining hemoglobin levels, hypotension, and features of 
hemorrhagic shock all suggest splenic hemorrhage.6,7 Due to 
its non-specific clinical picture, it can easily be mistaken for 
peptic ulcer disease or cardiac disease in the absence of 
trauma. Diagnosis should especially be considered in a 
patient who is on anticoagulation.7
Besides ultrasound can be urgently performed in these 
patients for rapid diagnosis,8 it can detect free fluid with 90% 
sensitivity and 99% specificity13 and can aid in early diagno-
sis and urgent consultations and guide treatment plans in 
cases with undifferentiated hypotension.14 CT scan is a rec-
ommended imaging modality for diagnosis, staging, and 
decision on surgical management.8 Initial management 
includes discontinuation of anticoagulants, volume resusci-
tation, and, if available, reversal of anticoagulation. Volume 
resuscitation with intravenous isotonic crystalloids offers the 
same benefit as colloids.15 PCC, FFP, and recombinant acti-
vated factor VII can be used in this setting despite lack of 
evidence.3 Current guidelines recommend RBC transfusion, 
platelet, and cryoprecipitate transfusion to maintain target 
hemoglobin >7 g/dL, platelet count >50,000/µL, and fibrin-
ogen >100 mg/dL, respectively.15 With andexanet alfa being 
approved by FDA for reversal of anticoagulation in life-
threatening or uncontrolled bleeding,16 it will be interesting 
Figure 1. CT scan of the abdomen/pelvis showing large 
subcapsular hematoma and active extravasation from the spleen 
with associated hemoperitoneum.
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to know its efficacy in patients with splenic hemorrhage. 
Surgical options for splenic rupture include conservative 
transcatheter arterial embolization and open surgical explo-
ration.9 Spontaneous splenic hemorrhage can be managed 
conservatively with close monitoring if the patient is hemo-
dynamically stable without signs of active hemorrhage or 
peritonitis.6,7 Embolization can be tried in hemodynamically 
stable patients with active contrast extravasation noted in CT 
angiography.17 Emergent laparotomy with splenectomy 
should be performed in hemodynamically unstable patients.7
Conclusion
Atraumatic splenic hemorrhage is life-threatening, and high 
index of suspicion for this should be maintained in patients 
presenting with abdominal pain, features of hypotension, 
and hemorrhagic shock while on apixaban. We hope this 
case will bring forward more similar reports in the future.
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